SKI Market

A+| A| A-|

Indian Indices

Sensex

77,844.52 -114.00
( -0.15%)

Global Indices

Nasdaq

49,922.52 603.26
(1.22%)

Dow Jones

7,387.39 107.17
(1.47%)

Hang Seng

62,916.52 3,403.40
(5.72%)

Nikkei 225

10,288.99 -149.67
(-1.43%)

Forex

USD-INR

95.18 0.09
(0.09%)

EUR-INR

111.29 -0.04
(-0.04%)

GBP-INR

128.89 -0.01
(-0.01%)

JPY-INR

0.60 0.00
(-0.23%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

BSE Bharat 22 Index

Industry : Stock Exchanges

BSE Code

ISIN Demat

Book Value()

1016

N.A

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

14.86

5227975.76

EPS(TTM)

Face Value()

Div & Yield %

100

2.2

Back

Shilpa Medicare enters into development and supply agreement with NXI Therapeutics AG

Feb 13,2026

Shilpa Medicare (SML) has entered into a binding agreement with NXI Therapeutics AG based out of Basel, Switzerland for development, supply of a New Chemical Entity (NCE). Under the terms of the strategic collaboration, SML will support both development – including first-in-human clinical studies – as well as long-term commercial supply with GMP manufacturing.

77,844.52 -114.00 ( -0.15%)

49,922.52 603.26 (1.22%)

7,387.39 107.17 (1.47%)

62,916.52 3,403.40 (5.72%)

10,288.99 -149.67 (-1.43%)

95.18 0.09 (0.09%)

111.29 -0.04 (-0.04%)

128.89 -0.01 (-0.01%)

0.60 0.00 (-0.23%)